Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1260092-44-1
1365655-91-9
756525-91-4
882847-13-4
1347750-75-7
1347750-78-0
2182601-75-6 | Nh-bis(peg4-boc) | AA019ECX | MFCD31536762
287384-28-5 | BDP TMR carboxylic acid | AA019EGQ | MFCD31580084
1823271-87-9 | tert-Butyl 2-((benzyloxy)methyl)-1,8-diazaspiro[4.5]decane-8-carboxylate | AA019EK3 | MFCD27997371
587878-72-6 | (9H-fluoren-9-yl)methyl (3-ethynylphenyl)carbamate | AA019EN8 | MFCD30691227
153025-65-1 | ethyl 4-((tert-butyldimethylsilyl)oxy)benzoate | AA019EQ9 | MFCD08693139
1421312-33-5 | Methyl 1-chloro-4-hydroxy-7-phenoxyisoquinoline-3-carboxylate | AA019ETD | MFCD29075513
497147-90-7 | 4,5-Diamino-2-chlorobenzonitrile | AA019EWM | MFCD20719621
63896-08-2 | 1-methyl-2-methylsulfanyl-5,6-dihydro-4H-pyrimidine | AA019EZ9 | MFCD00835252
51330-27-9 | Soyasaponin BB | AA019FUA | MFCD02752366
1397007-38-3 | 2-[(2-bromophenyl)formamido]-3-methylbutanoic acid | AA019GFF | MFCD00573185